Prosecution Insights
Prosecution Insights
19 pending office actions • 16 art units • 19 examiners • 0 of 19 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 19 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 19 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 13 (68%) |
| §112 only | 1 (5%) |
| Double-patenting + other | 1 (5%) |
| No statute on record | 4 (21%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRUTUS, JOEL F | 1 | 72.5% | +17.9% |
| LEE, ANDREW P | 1 | 48.5% | +23.4% |
| LUAN, SCOTT | 1 | 64.6% | +12.3% |
| HAUK TEODORO, PRICILA NMN | 1 | 100.0% | +0.0% |
| RIGA, MICHAEL ANGELO | 1 | 51.8% | +63.5% |
| SCHMITT, MICHAEL J | 1 | 56.6% | +21.7% |
| STEVENS, MARK V | 1 | 65.4% | +42.8% |
| HOLTZMAN, KATHERINE ANN | 1 | 64.5% | +57.9% |
| MI, QIUWEN | 1 | 68.2% | +49.9% |
| NEAGU, IRINA | 1 | 46.6% | +57.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18522521 | PERIPLASMIC LIGAND TRAPPING SYSTEM | HAUK TEODORO, PRICILA NMN | 25d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18720585 | AUGMENTED AND MIXED REALITY INCORPORATING PATHOLOGY RESULTS IN SURGICAL SETTINGS | BRUTUS, JOEL F | 128d overdue |
| 18039897 | METHOD OF TREATING POLYAMINE IMBALANCE-RELATED DISORDERS | SCHMITT, MICHAEL J | 100d overdue |
| 18135795 | METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF GRAFT VERSUS HOST DISEASE | MI, QIUWEN | 77d overdue |
| 17909194 | CANNABIDIOL NANODRUG FORMULATIONS AND METHODS FOR USE OF THE SAME | STEVENS, MARK V | 71d overdue |
| 18628644 | ROBOTIC SYSTEMS, DEVICES, AND METHODS FOR VASCULAR ACCESS | LUAN, SCOTT | 30d overdue |
| 18306956 | INNATE IMMUNE PROTEINS AS BIOMARKERS FOR TRAUMATIC BRAIN INJURY IN ADULT AND PEDIATRIC PATIENTS | HOLTZMAN, KATHERINE ANN | 19d overdue |
| 18028338 | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS AND ALLEVIATING FATIGUE | NEAGU, IRINA | 3d overdue |
| 18672929 | METHODS FOR TREATING MUCOPOLYSACCHARIDOSIS | LEE, ANDREW P | 39d |
| Art Unit | Apps |
|---|---|
| 1645 | 2 |
| 1629 | 2 |
| 1646 | 2 |
| 3797 | 1 |
| 1691 | 1 |
| 3792 | 1 |
| 1634 | 1 |
| 1613 | 1 |
| 1655 | 1 |
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18720585 | AUGMENTED AND MIXED REALITY INCORPORATING PATHOLOGY RESULTS IN SURGICAL SETTINGS | BRUTUS, JOEL F | 3797 | §103 | Non-Final OA | 128d overdue | Pending | Jun 14, 2024 |
| 18672929 | METHODS FOR TREATING MUCOPOLYSACCHARIDOSIS | LEE, ANDREW P | 1691 | Other | Non-Final OA | 39d | Pending | May 23, 2024 |
| 18628644 | ROBOTIC SYSTEMS, DEVICES, AND METHODS FOR VASCULAR ACCESS | LUAN, SCOTT | 3792 | §103 | Final Rejection | 30d overdue | Pending | Apr 05, 2024 |
| 18522521 | PERIPLASMIC LIGAND TRAPPING SYSTEM | HAUK TEODORO, PRICILA NMN | 1645 | §103 | Non-Final OA | 25d overdue | Pending | Nov 29, 2023 |
| 18556593 | ENGINEERED MEGANUCLEASES THAT TARGET HUMAN MITOCHONDRIAL GENOMES | RIGA, MICHAEL ANGELO | 1634 | DPOther | Non-Final OA | 69d | Pending | Oct 20, 2023 |
| 18039897 | METHOD OF TREATING POLYAMINE IMBALANCE-RELATED DISORDERS | SCHMITT, MICHAEL J | 1629 | §103 | Non-Final OA | 100d overdue | Pending | Jun 01, 2023 |
| 17909194 | CANNABIDIOL NANODRUG FORMULATIONS AND METHODS FOR USE OF THE SAME | STEVENS, MARK V | 1613 | §103 | Final Rejection | 71d overdue | Pending | May 15, 2023 |
| 18306956 | INNATE IMMUNE PROTEINS AS BIOMARKERS FOR TRAUMATIC BRAIN INJURY IN ADULT AND PEDIATRIC PATIENTS | HOLTZMAN, KATHERINE ANN | 1646 | Other | Non-Final OA | 19d overdue | Pending | Apr 25, 2023 |
| 18135795 | METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF GRAFT VERSUS HOST DISEASE | MI, QIUWEN | 1655 | §103 | Non-Final OA | 77d overdue | Pending | Apr 18, 2023 |
| 18028338 | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS AND ALLEVIATING FATIGUE | NEAGU, IRINA | 1629 | §103 | Final Rejection | 3d overdue | Pending | Mar 24, 2023 |
| 18187960 | CHEMERIN INHIBITORS AND USES THEREOF FOR TREATING KIDNEY CANCER | METCALF, MATTHEW CURRAN | 1647 | §103 | Non-Final OA | 79d overdue | Pending | Mar 22, 2023 |
| 18176396 | STING-DEPENDENT ACTIVATORS FOR TREATMENT OF DISEASE | CHONG, KIMBERLY | 1636 | Other | Non-Final OA | 19d overdue | Pending | Feb 28, 2023 |
| 17915971 | PHOTODYNAMIC ANTIMICROBIAL THERAPY DEVICE | SCHMITT, BENJAMIN ALLYN | 3796 | §103 | Final Rejection | 27d | Pending | Sep 29, 2022 |
| 17759139 | VACCINATION AGAINST ANTIGENS INDUCED IN PATHOGEN-INFECTED CELLS | PUTTLITZ, KARL J | 1646 | §112 | Non-Final OA | 9d | Pending | Jul 20, 2022 |
| 17785524 | Methods for Identifying Modulators of G Protein-Coupled Receptors | GRASER, JENNIFER E | 1645 | §103 | Final Rejection | 72d | Pending | Jun 15, 2022 |
| 17774892 | TARGETED DELIVERY OF NANOCARRIER-CONJUGATED DOXORUBICIN | BOWLES, DAVID PAUL | 1654 | §103 | Non-Final OA | 31d overdue | Pending | May 06, 2022 |
| 17639510 | QUANTIFICATION OF SYMMETRY AND REPEATABILITY IN LIMB MOTION FOR TREATMENT OF ABNORMAL MOTION PATTERNS | LOPEZ, SEVERO ANTON P | 3791 | §103 | Final Rejection | 9d overdue | Pending | Mar 01, 2022 |
| 17470707 | METHODS AND SYSTEMS FOR RETROFITTING A MANUAL OPHTHALMIC DEVICE FOR REMOTE OPERATION | DINH, JACK | 2872 | §103 | Final Rejection | 127d overdue | Pending | Sep 09, 2021 |
| 17396304 | Growth Hormone-Releasing Hormone Antagonists and Uses Thereof | STEELE, AMBER D | 1658 | Other | Non-Final OA | 26d | Pending | Aug 06, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial